64 related articles for article (PubMed ID: 19956852)
1. A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.
Van Geer MA; Brevoord D; Kuhlmann KF; Bakker CT; Mizuguchi H; Wesseling JG; Ten Kate FJ; Gouma DJ; Oude Elferink RP; Bosma PJ
Int J Oncol; 2010 Jan; 36(1):233-44. PubMed ID: 19956852
[TBL] [Abstract][Full Text] [Related]
2. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
[TBL] [Abstract][Full Text] [Related]
3. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
[TBL] [Abstract][Full Text] [Related]
5. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo.
van Geer MA; Bakker CT; Koizumi N; Mizuguchi H; Wesseling JG; Oude Elferink RP; Bosma PJ
World J Gastroenterol; 2009 Jun; 15(22):2754-62. PubMed ID: 19522026
[TBL] [Abstract][Full Text] [Related]
6. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.
Nicklin SA; Von Seggern DJ; Work LM; Pek DC; Dominiczak AF; Nemerow GR; Baker AH
Mol Ther; 2001 Dec; 4(6):534-42. PubMed ID: 11735337
[TBL] [Abstract][Full Text] [Related]
7. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
8. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
9. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
Mizuguchi H; Koizumi N; Hosono T; Utoguchi N; Watanabe Y; Kay MA; Hayakawa T
Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
[TBL] [Abstract][Full Text] [Related]
10. Cancer-targeting gene therapy using tropism-modified adenovirus.
Tanaka T; Kuroki M; Hamada H; Kato K; Kinugasa T; Shibaguchi H; Zhao J; Kuroki M
Anticancer Res; 2007; 27(6A):3679-84. PubMed ID: 17970028
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
12. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
Rittner K; Schreiber V; Erbs P; Lusky M
Cancer Gene Ther; 2007 May; 14(5):509-18. PubMed ID: 17318198
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871
[TBL] [Abstract][Full Text] [Related]
14. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
15. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
[TBL] [Abstract][Full Text] [Related]
16. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.
Kanerva A; Wang M; Bauerschmitz GJ; Lam JT; Desmond RA; Bhoola SM; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
Mol Ther; 2002 Jun; 5(6):695-704. PubMed ID: 12027553
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
19. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.
Noblitt LW; Bangari DS; Shukla S; Mohammed S; Mittal SK
Cancer Gene Ther; 2005 Jan; 12(1):46-53. PubMed ID: 15486559
[TBL] [Abstract][Full Text] [Related]
20. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B
Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
